Australia markets closed

Edgewise Therapeutics, Inc. (EWTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
18.01+0.51 (+2.91%)
At close: 04:00PM EDT
18.05 +0.04 (+0.22%)
After hours: 06:02PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-105,850
-100,163
-67,640
-42,813
-17,123
Depreciation & amortisation
2,016
1,732
538
272
185
Stock-based compensation
18,594
17,560
10,924
4,404
354
Change in working capital
-1,888
-1,560
4,086
4,630
1,950
Accounts payable
848
-92
47
2,654
521
Other working capital
-99,394
-97,693
-58,181
-34,175
-14,837
Net cash provided by operating activities
-97,720
-91,948
-52,635
-33,507
-14,634
Cash flows from investing activities
Investments in property, plant and equipment
-1,674
-5,745
-5,546
-668
-203
Purchases of investments
-566,511
-255,866
-292,388
-288,203
-24,178
Sales/maturities of investments
353,721
364,497
227,357
46,644
0
Net cash used for investing activities
-214,464
102,886
-70,577
-242,227
-24,381
Cash flows from financing activities
Common stock issued
291,765
52,618
129,165
186,148
0
Other financing activities
-
-165
-251
-124
-
Net cash used provided by (used for) financing activities
294,218
53,166
129,639
186,384
120,278
Net change in cash
-17,966
64,104
6,427
-89,350
81,263
Cash at beginning of period
48,230
21,993
15,566
104,916
23,653
Cash at end of period
30,264
86,097
21,993
15,566
104,916
Free cash flow
Operating cash flow
-97,720
-91,948
-52,635
-33,507
-14,634
Capital expenditure
-1,674
-5,745
-5,546
-668
-203
Free cash flow
-99,394
-97,693
-58,181
-34,175
-14,837